Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation

Voriconazole has previously been associated with increased risk for cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients. Less is known about the risk in patients after hematopoietic cell transplantation (HCT).

http://ift.tt/2uYSUCA